Back to today’s briefing

Story perspectives

Germany Approves First Psilocybin Therapy for Depression Relief

7/31/2025

50 10

Summary

Story summary

Germany's medicine regulator has made a groundbreaking decision by approving psilocybin therapy for those battling treatment-resistant depression. This compassionate use program empowers licensed psychiatrists to prescribe psilocybin, ensuring patient safety. Notably, Filament Health's PEX010 becomes the first psilocybin drug authorized in the EU, offering hope to many seeking relief.

1 of 1

Story summary

Germany's medicine regulator has made a groundbreaking decision by approving psilocybin therapy for those battling treatment-resistant depression. This compassionate use program empowers licensed psychiatrists to prescribe psilocybin, ensuring patient safety. Notably, Filament Health's PEX010 becomes the first psilocybin drug authorized in the EU, offering hope to many seeking relief.